Need help?

New element order is copied to your clipboard. Please paste it in the Element order variable.
Roche
2

  

COVID-19 Rapid Antigen Testing
Solutions for Professional Use

Roche solutions offer a fast and effective way to help protect businesses from COVID-19, enabling further confidence in a COVID-19 Safety Plan.
3
4

Lorem ipsum dolor sit amet consectetur

5

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut erat elit, hendrerit id metus id, facilisis faucibus ante. Cras scelerisque euismod orci, non iaculis erat efficitur quis. Maecenas nec libero at leo iaculis dapibus. Praesent ornare magna non ipsum elementum, sed pharetra sem porttitor. Aenean sit amet hendrerit urna.

6

The COVID-19 Rapid Antigen Self-Test (for home use) is intended for unsupervised testing in the home or other environment.
The COVID-19 Rapid Antigen Point of Care (POC) tests (for professional use) are intended for use at the point of care and must be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the goods and the interpretation of the test results. These tests must not be supplied for the purpose of self-testing.
Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained).
Follow current government health messaging regarding polymerase chain reaction (PCR) testing requirements.

7

Optional overline


Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic. Testing is a critical part in fighting this unprecedented global healthcare emergency and we are proud to be able to contribute.

Our rapid testing solutions not only add a layer of confidence to your employees but can act as part of a risk mitigation strategy to protect your business continuity and help keep your business running. 

Protect your workforce and maximise productivity. Talk to us today about how we can help your COVID-19 Safety Plan.
8

Optional overline



Roche’s response to the COVID-19 pandemic

We are deeply committed to supporting the global response to put an end to the COVID-19 pandemic. Testing is a critical part in fighting this unprecedented global healthcare emergency and we are proud to be able to contribute.


9

Optional overline

 

Roche tests able to detect
new Omicron variant

Roche can confirm our PCR, antibody and antigen tests can detect the new Omicron virus variant. To view the full list of tests click here.
10

Rapid testing types provided by Roche

To find out more, request a callback or download the brochure.


Help protect your business with a COVID-19 rapid testing solution from Roche

11
12
13
14
15
16

Our Rapid Testing Solutions

 
SARS-CoV-2 Rapid Antigen Test
Included on the ARTG (ID:352250)
Testing ready to go when you need to know
SARS-CoV-2 Rapid Antigen Test allows for decentralised testing and enables fast decision making in diverse settings.

 
SARS-CoV-2 Antigen Self Test Nasal
Included on the ARTG (ID:352250)
Available now for self-testing
Reliable SARS-CoV-2 antigen test results in just 15 minutes for unsupervised testing in the home or other environment.
 
NAVIFY® Pass Solution

An end-to-end digital COVID-19 Solution
NAVIFY® Pass aids test providers and recipients to share diagnostic results securely, remotely and seamlessly.
Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

17
18
Contact our experts for further information and learn how to add testing to your COVID-19 Safety Plan today.
21

COVID-19 Scientific Webinar Series

1st Webinar
Coagulopathy in COVID-19
15:00 - 16:15 CET
Welcome and introduction
Prof. Nicole Juffermans
Thrombotic and haemostatic issues in intensive care, which challenges do we face and what the biomarkers tell us
13:30-13:45
Prof. Edwin J.R. van Beek
Role of Radiology and plasma D-dimer in pathophysiological aspects and treatment of COVID-19
13:30-13:45
Dr. Michelle Sholzberg
Anticoagulation & therapeutic management :
Which treatment fits best and how can we monitor?
13:30-13:45
Q& session
2nd Webinar
Lorem ipsum 08 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. James Januzzi
Is a member of the Massachusetts General Hospital Cardiology Division. He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute
13:30-13:45
Dr. Raphael Twerenbold
Is an interventional cardiologist and senior physician at the Clinic for Cardiology at the University Hospital Basel
13:30-13:45
Prof. Alexandre Mebazaa
Is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France
13:30-13:45
Dr. Zhou Ning
Associate Professor, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
13:30-13:45
Q& session
3rd Webinar
Lorem ipsum 14 July 2020
15:00 - 16:15 CET
Welcome and introduction
W. Conrad Liles
MD, PhD, University of Washington, Seattle, US
13:30-13:45
Tobias Weinberger
MD, Ludwig Maximilian University of Munich, Munich, Germany
13:30-13:45
Q& session
4th Webinar
Lorem ipsum 16 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. Anna Kajdy
Head of Obstetrics Department, St. Sophie's Obstetrics and Gynecology Hospital, Warsaw, Poland
13:30-13:45
Prof. Liona Poon
Clinical Professor, Obstetrics, CUHK, Hong Kong
13:30-13:45
Q& session
22

Title

Lorem ipsum dolor sit amet.

Click here

Lorem ipsum dolor sit amet.

Click here

Lorem ipsum dolor sit amet.

Click here

Lorem ipsum dolor sit amet.

Click here
23
24

Focus and
Products

We don’t believe in keeping the best brains in boxes. If our scientists have a great idea, we’ll make sure that they have what they need to try it out, fast. By doing this can we produce the innovation society desperately needs, and quickly rule out unsuccessful hypotheses.

25

Headline 1

Antibodies play an important role in our immune systems, defending our bodies from invaders like viruses. By making antibody medicines, we can help fight a variety of diseases. Read on to find out more about the complex processes involved.

arrow
26

I wouldn't call it resistance, I would call it practical hurdles that need to be overcome, this is a complex road.

Gérard Xavier Marcel Depardieu

French actor